<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36805019</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-0442</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><PubDate><Year>2023</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>Travel medicine and infectious disease</Title><ISOAbbreviation>Travel Med Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Cognitive dysfunction, diabetes mellitus 2 and arterial hypertension: Sequelae up to one year of COVID-19.</ArticleTitle><Pagination><StartPage>102553</StartPage><MedlinePgn>102553</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tmaid.2023.102553</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1477-8939(23)00013-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Covid symptoms reflect its multisystem nature, in addition to its positive relationship between the severity of the condition and the severity of the long COVID.</AbstractText><AbstractText Label="OBJECTIVE">To identify the factors associated with the prevalence of SEQUELAE DUE TO COVID-19 one year after their hospital discharge due to severe pneumonia.</AbstractText><AbstractText Label="METHOD">Longitudinal, analytical, prospective and comparative study. 71 covid-19 pneumonia survivors were followed. Two telephone interviews were conducted to each patient; the first at 5 months of discharge and the second at 12 months from the mentioned date. We included questions of 40 symptoms, in addition to the questioning of diabetes mellitus and/or systemic hypertension with a mentioned onset during the hospitalization or after hospital discharge due to COVID-19.</AbstractText><AbstractText Label="RESULTS">Of the 37 patients without complications and without comorbidities prior to hospitalization, 11 (29.7%) developed arterial hypertension during or after discharge and 17 (45.9%) developed diabetes mellitus before five months. Short-term memory loss was an upward sequel in the two measurements, 24.3% and 41.9% respectively.</AbstractText><AbstractText Label="CONCLUSIONS">Type 2 diabetes mellitus and high blood pressure detected at five months was temporary and reversed in many cases at twelve months. It will be important to deepen the study of brain damage and cognitive dysfunction, characterized by memory loss.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Ortega</LastName><ForeName>Miguel &#xc1;</ForeName><Initials>M&#xc1;</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n en Pol&#xed;ticas, Poblaci&#xf3;n y Salud, Facultad de Medicina, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Ciudad de M&#xe9;xico, Mexico. Electronic address: miguelaf03@live.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ponce-Rosas</LastName><ForeName>Efr&#xe9;n R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Subdivisi&#xf3;n de Medicina Familiar, Divisi&#xf3;n de Estudios de Posgrado, Facultad de Medicina, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Ciudad de M&#xe9;xico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu&#xf1;iz-Salinas</LastName><ForeName>Daniel A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n en Pol&#xed;ticas, Poblaci&#xf3;n y Salud, Facultad de Medicina, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Ciudad de M&#xe9;xico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Mendoza</LastName><ForeName>Omar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n en Pol&#xed;ticas, Poblaci&#xf3;n y Salud, Facultad de Medicina, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Ciudad de M&#xe9;xico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>N&#xe1;jera Ch&#xe1;vez</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hospital Regional "Lic. Adolfo L&#xf3;pez Mateos". Instituto de Seguridad y Servicios Sociales de Los Trabajadores Del Estado. Ciudad de M&#xe9;xico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-Pozos</LastName><ForeName>Ver&#xf3;nica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Servicio de Cirug&#xed;a Maxilofacial, Hospital Regional "Lic. Adolfo L&#xf3;pez Mateos". Instituto de Seguridad y Servicios Sociales de Los Trabajadores Del Estado, Ciudad de M&#xe9;xico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xe1;vila-Mendoza</LastName><ForeName>Roc&#xed;o</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Subdivisi&#xf3;n de Medicina Familiar, Divisi&#xf3;n de Estudios de Posgrado, Facultad de Medicina, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Ciudad de M&#xe9;xico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrell</LastName><ForeName>Alan E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Direcci&#xf3;n M&#xe9;dica, Productos Farmac&#xe9;uticos, S.A. de C.V, Ciudad de M&#xe9;xico, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Travel Med Infect Dis</MedlineTA><NlmUniqueID>101230758</NlmUniqueID><ISSNLinking>1477-8939</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Diabetes mellitus</Keyword><Keyword MajorTopicYN="N">Disfunci&#xf3;n cognitiva (cognitive dysfunction)</Keyword><Keyword MajorTopicYN="N">Hypertension</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Pneumonia</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Sequelae</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>9</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36805019</ArticleId><ArticleId IdType="pmc">PMC9981335</ArticleId><ArticleId IdType="doi">10.1016/j.tmaid.2023.102553</ArticleId><ArticleId IdType="pii">S1477-8939(23)00013-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>COVID-19 map - johns Hopkins Coronavirus resource Center [Internet]  Jhu.edu. [citado el 21 de marzo de 2022]. Disponible en. https://coronavirus.jhu.edu/map.html</Citation></Reference><Reference><Citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., et al. A novel Coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Enfermedad por coronavirus. https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/ITCoronavirus.pdf. Spanish SARS-COV-2 [Internet]. [cited 2021 Jul 7]. Available from:</Citation></Reference><Reference><Citation>de Garc&#xed;a J. ENTENDIENDO LA fisiopatolog&#xed;a DE COVID -19. Central American journals OnlineCentral American journals online. el 10 de septiembre de. 2020;13(1):44&#x2013;47.</Citation></Reference><Reference><Citation>Mahase E. Covid-19: what do we know about &#x201c;long covid&#x201d;. BMJ. 2020;370:m2815.</Citation><ArticleIdList><ArticleId IdType="pubmed">32665317</ArticleId></ArticleIdList></Reference><Reference><Citation>Ch&#xe9;rrez-Ojeda I., Gochicoa-Rangel L., Salles-Rojas A., Mautong H. Seguimiento de los pacientes despu&#xe9;s de neumon&#xed;a por COVID-19. Secuelas pulmonares. Rev Alerg Mex. 2020;67(4):350&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">33631903</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., et al. M&#xe1;s de 50 efectos a largo plazo de COVID-19: una revisi&#xf3;n sistem&#xe1;tica y metan&#xe1;lisis. Informe cient&#xed;fico. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S.J., McIvor C., Whyatt G., Adams A., Harvey O., McLean L., et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93(2):1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Koh G.C.H., Car J. Covid-19: a remote assessment in primary care. BMJ. 2020;368:m1182.</Citation><ArticleIdList><ArticleId IdType="pubmed">32213507</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez del Castillo J., Rodr&#xed;guez Machuca M.J., Casasus M.A., S&#xe1;nchez Garc&#xed;a A. Secuelas de la infecci&#xf3;n por SARS-CoV-2. Un problema que debe ser afrontado. Rev Med Chile. 2020;148(9):1373.</Citation><ArticleIdList><ArticleId IdType="pubmed">33399717</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., O'Connor L., Leavy D., O'Brien K., Dowds J., Sugrue J.A., Hopkins D., Martin-Loeches I., Ni Cheallaigh C., Nadarajan P., McLaughlin A.M., Bourke N.M., Bergin C., O'Farrelly C.&#x2026;Conlon N. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15(11) doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg E., van Willigen H.D.G., Dijkstra M., Boyd A., Kootstra N.A., van den Aardweg J.G., van Gils M.J., Matser A., de Wit M.R., Leenstra T., de Bree G., de Jong M.D., Prins M., Agard I., Ayal J., Cavdar F., Craanen M., Davidovich U., Deuring A.&#x2026;van Wijk M. Evolution of coronavirus disease 2019 (COVID-19) symptoms during the first 12 Months after illness onset. Clin Infect Dis. 2021 doi: 10.1093/cid/ciab759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab759</ArticleId><ArticleId IdType="pmc">PMC8522402</ArticleId><ArticleId IdType="pubmed">34473245</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., Mitchell R.E., Niedzwiedz C.L., Yang T.C., Huggins C.F., Kwong A.S.F., Silverwood R.J., Gessa G.D., Bowyer R.C., Northstone K., Hou B., Green M.J., Dodgeon B., Doores K.J., Duncan E.L., Williams F.M.K., Steptoe A., Steves C.J. medRxiv; 2021. Risk factors for long COVID: analyses of 10 longitudinal studies and electronic health records in the UK.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.24.21259277</ArticleId></ArticleIdList></Reference><Reference><Citation>Oficina Nacional de Estad&#xed;sticas del Reino Unido  COVID-19. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/2december2021 Fecha de acceso: 25 de mayo de 2022.</Citation></Reference><Reference><Citation>Boscolo-Rizzo P., Guida F., Polesel J., et al. Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19) Int Forum Allergy Rhinol. 2021;11:1685&#x2013;1688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9291310</ArticleId><ArticleId IdType="pubmed">34109765</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Ortega M.A., N&#xe1;jera-Ch&#xe1;vez P., Ponce-Rosas E.R., D&#xe1;vila-Mendoza R., Rodr&#xed;guez-Mendoza O., Mu&#xf1;iz-Salinas D.A. Oximetr&#xed;a de ingreso hospitalario y prote&#xed;na C reactiva: factores pron&#xf3;stico para desenlace fatal por COVID-19. Rev Mex Med Fam. 2022;8:86&#x2013;92.</Citation></Reference><Reference><Citation>Fern&#xe1;ndez-Ortega M.A., N&#xe1;jera-Ch&#xe1;vez P., Ponce-Rosas E.R., D&#xe1;vila-Mendoza R., Mu&#xf1;iz-Salinas D.A., Rodr&#xed;guez-Mendoza O., S&#xe1;nchez-Pozos V., Pliego-Reyes C.L. Efecto de la comunicaci&#xf3;n con dispositivos m&#xf3;viles en pacientes hospitalizados por COVID-19. Med Int Mex. 2022;38(4):804&#x2013;810.</Citation></Reference><Reference><Citation>Montefusco L., Ben Nasr M., D'Addio F., et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab. 2021;3:774&#x2013;785. doi: 10.1038/s42255-021-00407-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00407-6</ArticleId><ArticleId IdType="pmc">PMC9931026</ArticleId><ArticleId IdType="pubmed">34035524</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezel-Potts E., Douiri A., Sun X., Chowienczyk P.J., Shah A.M., Gulliford M.C. Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK. PLoS Med. 2022;19(7) doi: 10.1371/journal.pmed.1004052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004052</ArticleId><ArticleId IdType="pmc">PMC9295991</ArticleId><ArticleId IdType="pubmed">35853019</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee Mainak, Pal Rimesh, Dutta Sulagna. Primary Care Diabetes; 2022. Risk of incident diabetes post-COVID-19: a systematic review and meta-analysis.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9148988</ArticleId><ArticleId IdType="pubmed">35654679</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T., Tapp R.J., Cooper M.E., Zimmet P. Potential metabolic and inflammatory pathways between SARS-COV-2 and new-onset diabetes. Diabetes Metab. 2021;47(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7591867</ArticleId><ArticleId IdType="pubmed">33129968</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan W., Zhang J., Wang M., Ye J., Xu Y., Shen B., et al. Clinical features of SARS-COV-2 in patients with essential hypertension and the impacts of renin-angiotensin-aldosterone system inhibitors on the prognosis of SARS-COV-2 patients. Hypertension. 2020;76(3):732&#x2013;741.</Citation><ArticleIdList><ArticleId IdType="pubmed">32654555</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiura T., Dohi Y., Yamashita S., Yamamoto K., Wakamatsu Y., Tanaka S., Kimura G. Impacto del perfil de l&#xed;pidos y la presi&#xf3;n arterial alta en el da&#xf1;o endotelial. J Clin Lipidol. 2011;5(6):460&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pubmed">22108149</ArticleId></ArticleIdList></Reference><Reference><Citation>Tadic M., Cuspidi C., Grassi G., Mancia G. COVID-19 and arterial hypertension: hypothesis or evidence? J Clin Hypertens. 2020 Jul;22(7):1120&#x2013;1126. doi: 10.1111/jch.13925. Epub 2020 Jul 6. PMID: 32627330; PMCID: PMC7362072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jch.13925</ArticleId><ArticleId IdType="pmc">PMC7362072</ArticleId><ArticleId IdType="pubmed">32627330</ArticleId></ArticleIdList></Reference><Reference><Citation>Portilla E., Portilla F., Corzo S. Una revisi&#xf3;n de literatura del s&#xed;ndrome pos-COVID-19. Educaci&#xf3;n M&#xe9;dica Superior. 2022;36(3)</Citation></Reference><Reference><Citation>Kim Y., et al. Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea. BMC Infect Dis. 2022;22(1):1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8793328</ArticleId><ArticleId IdType="pubmed">35086489</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Sillett R., Zhu L., Mendel J., Camplisson I., Dercon Q., Harrison P. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatr. 2022 doi: 10.1016/S2215-0366(22)00260-7. ISSN 2215-0366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurtubise J., McLellan K., Durr K., Onasanya O., Nwabuko D., Ndisang J.F. Las diferentes facetas de la dislipidemia y la hipertensi&#xf3;n en la aterosclerosis. Curr Atherosclerosis Rep. 2016;18(12):82.</Citation><ArticleIdList><ArticleId IdType="pubmed">27822682</ArticleId></ArticleIdList></Reference><Reference><Citation>Altuna M., S&#xe1;nchez-Saudin&#xf3;s MaB., Lle&#xf3; A. Cognitive symptoms after COVID-19. Neurology Perspectives. 2021;1(Supplement 1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8669718</ArticleId><ArticleId IdType="pubmed">38620975</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrilli C.M., Jones S.A., Yang J., Rajagopalan H., O'Donnell L., Chernyak Y., et al.  Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. [internet] 2020 https://www.bmj.com/content/bmj/369/bmj.m1966.full.pdf 369:m1966. [cited 2021 Sep 28]. Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243801</ArticleId><ArticleId IdType="pubmed">32444366</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Li L., Xu M., Wu J., Luo D., Zhu Y., Li B., Song X., Zhou X. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with SARS-COV-2. J Clin Virol. 2020 Jun;127 doi: 10.1016/j.jcv.2020.104370. Epub 2020 Apr PMID: 32344321; PMCID: PMC7194648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104370</ArticleId><ArticleId IdType="pmc">PMC7194648</ArticleId><ArticleId IdType="pubmed">32344321</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E.  Vol. 6. 2022. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC) - cardiovascular Diabetology.https://cardiab.biomedcentral.com/articles/10.1186/s12933-022-01579-5 (BioMed ccentral).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J.K., Feng Y., Yuan M.Y., Yuan S.Y., Fu H.J., Wu B.Y., et al. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS-CoV. Diabet Med. 2019;23(6):623&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pubmed">16759303</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J.P., Chesney E., Oliver D., Pollak T.A., McGuire P., Fusar-Poli P., et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatr. 2020;7:611&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasoni D., Bai F., Castoldi R., Barbanotti D., Falcinella C., Mul&#xe8; G., et al. Anxiety and depression symptoms after virological clearance of COVID-19: a cross-sectional study in Milan, Italy. J Med Virol. 2021;93:1175&#x2013;1179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461061</ArticleId><ArticleId IdType="pubmed">32841387</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>